STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Biomea Fusion to Participate at Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Biomea Fusion (Nasdaq: BMEA) will participate in a fireside chat at the Jefferies London Healthcare Conference on November 17, 2025 at 4:30 PM GMT and will hold one-on-one investor meetings on November 17–18, 2025 in London.

An audio webcast of the presentation will be available live and a replay will be posted on the company’s News & Events page under Investors & Media.

Biomea Fusion (Nasdaq: BMEA) parteciperà a un dibattito informale al Jefferies London Healthcare Conference il 17 novembre 2025 alle 16:30 GMT e terrà incontri one-to-one con gli investitori il 17–18 novembre 2025 a Londra.

Una webcast audio della presentazione sarà disponibile in diretta e la replica sarà pubblicata sulla pagina News & Events della società nella sezione Investors & Media.

Biomea Fusion (Nasdaq: BMEA) participará en una charla junto a la chimenea (fireside chat) en la Conferencia de Salud de Londres de Jefferies el 17 de noviembre de 2025 a las 4:30 p.m. GMT y llevará reuniones individuales con inversores los 17–18 de noviembre de 2025 en Londres.

Una transmisión por audio de la presentación estará disponible en vivo y una repetición se publicará en la página de News & Events de la empresa, en la sección Investors & Media.

Biomea Fusion (나스닥: BMEA)Jefferies London Healthcare Conference에서 2025년 11월 17일 오후 4시 30분 GMT에 파이어사이드 채팅에 참여하고 2025년 11월 17–18일에 런던에서 일대일 투자자 미팅을 개최합니다.

오디오 webcast 형식의 발표가 생중계로 제공되며, 회사의 News & Events 페이지의 Investors & Media 섹션에 다시보기가 게시됩니다.

Biomea Fusion (Nasdaq : BMEA) participera à un fireside chat lors de la Jefferies London Healthcare Conference le 17 novembre 2025 à 16h30 GMT et mènera des entretiens individuels avec des investisseurs les 17–18 novembre 2025 à Londres.

Une webcast audio de la présentation sera disponible en direct et une rediffusion sera publiée sur la page News & Events de l'entreprise dans la section Investors & Media.

Biomea Fusion (Nasdaq: BMEA) wird an einem Fireside-Chat auf der Jefferies London Healthcare Conference am 17. November 2025 um 16:30 Uhr GMT teilnehmen und am 17.–18. November 2025 in London One-on-One-Investorengespräche führen.

Eine Audio-Webcast der Präsentation wird live verfügbar sein, und eine Aufzeichnung wird auf der News & Events-Seite des Unternehmens unter Investors & Media veröffentlicht.

Biomea Fusion (ناسداك: BMEA) ستشارك في دردشة fireside في مؤتمر Jefferies London Healthcare في 17 نوفمبر 2025 الساعة 4:30 مساءً بتوقيت GMT وستعقد اجتماعات مع المستثمرين بشكل فردي في 17–18 نوفمبر 2025 في لندن.

سيكون بث صوتي مباشر لعرض تقديمي متاحاً مباشرة، وسيتم نشر إعادة العرض في صفحة أخبار & الأحداث التابعة للشركة ضمن Investors & Media.

Positive
  • None.
Negative
  • None.

SAN CARLOS, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it is scheduled to participate in a fireside chat at the upcoming Jefferies London Healthcare Conference on November 17, 2025 at 4:30 PM (GMT) and will participate in one-on-one meetings on November 17-18, 2025 in London, UK.

An audio webcast of the presentation will be available here or by visiting the News & Events Page under the Investors & Media section of Biomea’s website. A replay of the webcast will be available following the live event.

About Biomea Fusion
Biomea Fusion is a clinical-stage biopharmaceutical company advancing oral small molecule therapies for diabetes and obesity; icovamenib, a selective menin inhibitor for diabetes and BMF-650, a next-generation oral GLP-1 receptor agonist for obesity. These programs target cardiometabolic disorders, a global health challenge affecting nearly half of Americans and one-fifth of the world’s population. Biomea’s mission is to deliver transformative treatments that restore health for patients living with diabetes, obesity, and related conditions. We aim to cure.

Visit us at biomeafusion.com and follow us on LinkedIn, X and Facebook.

Contact: 
Meichiel Jennifer Weiss
Sr. Director of Investor Relations and Corporate Development
ir@biomeafusion.com


FAQ

When will Biomea Fusion (BMEA) present at the Jefferies London Healthcare Conference?

Biomea Fusion will present in a fireside chat on November 17, 2025 at 4:30 PM GMT.

How can investors listen to Biomea Fusion's (BMEA) Jefferies conference presentation?

An audio webcast will stream live and a replay will be posted on the company’s News & Events page under Investors & Media.

Will Biomea Fusion (BMEA) meet with investors at Jefferies London Healthcare Conference?

Yes. Biomea Fusion is scheduled for one-on-one meetings on November 17–18, 2025 in London.

What time zone is the Biomea Fusion (BMEA) fireside chat scheduled in?

The fireside chat is scheduled at 4:30 PM GMT on November 17, 2025.

Where can I find the replay of Biomea Fusion's (BMEA) Jefferies presentation after the event?

The replay will be available on the company’s News & Events page in the Investors & Media section.

Is the Jefferies London Healthcare Conference presentation by Biomea Fusion (BMEA) relevant to shareholders?

Yes. The presentation and investor meetings provide updates and direct access to management for shareholders and analysts.
Biomea Fusion, Inc.

NASDAQ:BMEA

BMEA Rankings

BMEA Latest News

BMEA Latest SEC Filings

BMEA Stock Data

91.91M
65.18M
9.47%
48.39%
13.52%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN CARLOS